ライフサイエンスコーパス: ng

1 imits of detection in the range of 0.055-1.0 ng, and a measurement reproducibility of 5-28%.

2 patients (19%) with PCa early BCR (PSA < 1.0 ng/mL).

3 er RP with PSA readings between 0.05 and 1.0 ng/mL, considered eligible for SRT at the time of PSMA.

4 at baseline) and ranged from 25.0 to 1062.0 ng/mL (mean +/- SD: 191.7 +/- 354.2 ng/mL).

5 ate-specific antigen (PSA) (range, 0.3-119.0 ng/mL; mean, 10.1 +/- 21.3 ng/mL) and negative findings

6 state cancer and a PSA level higher than 4.0 ng/mL between 6 and 12 months after starting ADT.

7 L) and patients with AD dementia (mean, 51.0 ng/L) compared with controls (mean, 34.7 ng/L) (P < .001

8 ptimal operating point on the ROC curve (7.0 ng/mL) were both 93%.

9 nalized 25(OH)D concentration was 26.5 (9.0) ng/mL, with 1270 participants (24.9%) being vitamin D de

10 were found to be 0.1-1000 ng mL(-1) and 0.02 ng mL(-1), respectively.

11 (0.9999), a high detection limitation (0.03 ng/mL) and specificity (0-0.002%) for detection of GPC3.

12 compounds (TICs), ranged from 0.05 to 35.03 ng/g wet weight and from 0.03 to 3.32 muM in tuna lipid.

13 /=3 (which includes cardiac troponin I <0.04 ng/mL at 0 and 3 hours) were randomized to immediate dis

14 L(-1), and high sensitivity of 12.044microA (ng per mL cm(-2))(-1) with a response time of 5min.

15 tration was lower with viral pathogens (0.09 ng/mL; interquartile range [IQR], <0.05-0.54 ng/mL) than

16 = 3.54 +/- 3.39 ng/mL, peak = 7.13 +/- 6.09 ng/mL) but undetectable in all controls (p < 0.001).

17 sensitivity by 3 orders of magnitude to 0.1 ng/mL in buffer but also enable highly sensitive detecti

18 A procalcitonin threshold of 0.1 ng/mL resulted in 80.9% (95% CI, 75.3%-85.7%) sensitivit

19 TCS was detectable (>/=0.1 ng/mL) in 98.24% of maternal urine samples with tertile

20 ng mL(-1) (n = 9), a detection limit of 11.1 ng mL(-1), and a dynamic range from 17.3 to 79.6 ng mL(-

21 derate in fish muscle (e.g. , PFOS: 0.28-2.1 ng g(-1) wet-weight), with little or no differences when

22 -treated subjects had serum TXB2 levels >3.1 ng/ml, compared with 18% and 11% of subjects after admin

23 d (median, 4.9; interquartile range, 1.3-9.1 ng/mL).

24 e make a single library from approximately 1 ng of high molecular weight DNA, using the 10x Genomics

25 SpISO-seq requires less than 1 ng of input cDNA, limiting or removing the need for prio

26 atients with serum PSA levels of less than 1 ng/mL, determine how often consensus clinical target vol

27 r radiotherapy at a PSA level of less than 1 ng/mL.

28 cally relevant concentrations of LPS (0 to 1 ng/mL) cause an increase in intestinal epithelial tight

29 developing uveitis were 4% lower for every 1-ng/mL increase in vitamin D level (odds ratio, 0.96; 95%

30 retion, with optimal Pen a 1 doses of 0.1-10 ng/ml.

31 max to be 12.0 +/- 2.5 mug/mL and 170 +/- 10 ng/mL in the serum and brain, respectively, when compoun

32 re 2.5 ng on the Ion Torrent platform and 10 ng on Illumina.

33 ly sensitive detection of as low as 1 and 10 ng/mL of Zika NS1 to be carried out in 10% and 100% huma

34 The cumulative ADA positivity (>10 ng/mL) and low TL (<5.0 mug/mL) was 12.1% and 17.8% afte

35 had low-risk tumor characteristics (PSA < 10 ng/mL and Gleason score < 7), and 89.2% underwent active

36 PFOA concentrations from 1 mug L(-1) to <10 ng L(-1), at least 7 times lower than the 2016 U.S. EPA

37 the maximum AFP level before an LT was </=10 ng/mL).

38 p) (T1-T2; Gleason score, </=6; and PSA, <10 ng/mL), and intermediate-risk disease (T1-T2 with Gleaso

39 , </=6; prostate-specific antigen [PSA], <10 ng/mL; PSA density <0.15 ng/mL/cm3; and <8-mm total canc

40 A target testing limit of 10 ng/g in honey for the sulfonamides was used based upon a

41 tage) were microinjected with either 1 or 10 ng venlafaxine, which led to a rapid reduction (90%) of

42 surement of an IR spectrum from less than 10 ng of sample obtained in a collected HPLC fraction.

43 state-specific antigen level of less than 10 ng/mL and Gleason score 3 + 3 tumors.

44 ost samples at levels ranging from 0.5 to 10 ng As kg(-1), and was found at depths down to 4900 m.

45 on (LOQs) were within the range of 0.1 to 10 ng.mL(-1) for plasma and 0.25 to 10 ng.mL(-1) for urine.

46 .1 to 10 ng.mL(-1) for plasma and 0.25 to 10 ng.mL(-1) for urine.

47 binant human IL-12 (p70) in a dose- (0 to 10 ng/mL) and time-dependent manner.

48 L(-1) with a large dynamic range of 0.01-100 ng mL(-1) and high selectivity.

49 SP (0.01-1 muM) and IL-33 (1-100 ng/mL) in combination also greatly stimulate TNF secreti

50 ns smaller than 1000 particles/cm(3) and 100 ng/m(3), respectively, and a time resolution on the orde

51 Of 123 patients with a high AFP level (>100 ng/dL), 12 patients achieved restored normal AFP levels

52 hoton imaging, we found that infusion of 100 ng of HIV-1 Tat into the lateral ventricle of yellow flu

53 lation, but a threshold concentration of 100 ng/ml of SOF must be attained to suppress LDV-resistant

54 alpha fetoprotein (AFP) concentration of 100 ng/mL or lower and 101-1000 ng/mL; and the PRETEXT annot

55 static disease, and AFP concentration of 100 ng/mL or lower at diagnosis.

56 t of the procedure were found to be 0.1-1000 ng mL(-1) and 0.02 ng mL(-1), respectively.

57 entration of 100 ng/mL or lower and 101-1000 ng/mL; and the PRETEXT annotation factors metastatic dis

58 la and an extremely high concentration (1000 ng m(-3)) in the White Sea.

59 natural Holocene background of 0.27 +/- 0.11 ng m(-3).

60 tion plant, with highest concentration at 11 ng/L.

61 closan varied across pregnancy from 17 to 11 ng/mL, while in children, median concentrations increase

62 I: 0.34 (0.67) ng/mL, Group II: 0.11 (0.11) ng/mL, P = .01); vascular endothelial growth factor (VEG

63 e NEVKP group (1267 +/- 372 vs 2697 +/- 1145 ng/mL, P = 0.029).

64 34/35) displaying activity (range, 0.054-116 ng E2Eq L(-1)).

65 0ng/ml range with high sensitivity of 119nA/(ng/ml), with negligible interference from serum proteins

66 Method quantification limits were at 0.5-120 ng/L in wastewater.

67 high as 220 ng L(-1), 160 ng L(-1), and 120 ng L(-1), respectively.

68 e highest median concentration in dust (1200 ng/g), followed by EFRs (730 ng/g) and HBCDDs (190 ng/g)

69 assigned to receive carbonated water (26-121 ng/mL; mean +/- SD: 60.7 +/- 52.4 ng/mL).Despite the sel

70 her in patients with CT edema (4.96 +/- 1.13 ng/mL vs 2.10 +/- 0.34 ng/mL; p = 0.023).

71 nts achieved restored normal AFP levels (<13 ng/dL) and exhibited median overall survival of 23.9 mo

72 insufficient (13-20 ng/l) and deficient (<13 ng/l) 25(OH)D status groups (OR = 2.6,95% CI 1.7-1.1; OR

73 sma concentration (Cmax) ranged between 1310 ng/mL and 34 800 ng/mL and was reached in a median time

74 rations of OPFRs in sludge were between 4.14 ng/g dw for tripropyl phosphate (TPP) and 7290 ng/g dw f

75 baseline troponin I (> 40 ng/L) and T (> 14 ng/L), occurring in 56 of 412 (13.6%) and 101 of 407 (24

76 , and a steel factory were 48, 160, and 1400 ng/g d.w., respectively, in sediment sections dated from

77 Lower SCCPs concentrations (<57-1421 ng/g dw) were detected in the Australian sewage sludge,

78 antigen [PSA], <10 ng/mL; PSA density <0.15 ng/mL/cm3; and <8-mm total cancer length in </=4 positiv

79 of biomarkers was possible for analytes >15 ng/mL.

80 %, and 97% for iron deficiency (ferritin <15 ng/mL or 32 pmol/L), vitamin A deficiency (retinol-bindi

81 infusion of either ularitide at a dose of 15 ng per kilogram of body weight per minute or matching pl

82 TATP are equivalent to the deposition of 15 ng TATP and are comparable with other ambient desorption

83 ate-specific antigen concentrations up to 15 ng/mL, with no previous biopsy, underwent 1.5 Tesla MP-M

84 TETS concentration in the serum reached 150 ng/mL without significant change over 4 h post-treatment

85 oss a range of troponin concentrations (2-16 ng/L) using individual patient data.

86 and eight-arm PEG40K-NH2) at 3.2, 16, and 16 ng mL(-1), respectively.

87 oic acid (PFOA) as high as 220 ng L(-1), 160 ng L(-1), and 120 ng L(-1), respectively.

88 w for TBOEP; for ash, they were between 2.17 ng/g dw for TMPP and 427 ng/g dw for triphenyl phosphate

89 dian concentrations increased from 3.6 to 17 ng/mL over the first 4 years of life, declining slightly

90 n all urban and AFFF-impacted sites (0.04-19 ng/L) indicates the widespread presence of rarely consid

91 followed by EFRs (730 ng/g) and HBCDDs (190 ng/g).

92 lated; the time for complete ablation of 193 ng of sucrose particles was found to be approximately 2

93 her than outdoors and ranged from 0.5 to 194 ng/m(3) (PCBs) and from 4 to 665 pg/m(3) (OH-PCBs).

94 osensor exhibited high sensitivity of 194nA/(ng/ml) and 240nA/(ng/ml), respectively for single and do

95 or air concentrations ranged from 9.2 to 199 ng/m(3) for chlorpyrifos, 0.03 to 20 ng/m(3) for chlorpy

96 In patients with PSA levels below 0.2 ng/dL, 7 of 12 patients had disease detected on (68)Ga-P

97 A limit of detection of 0.2 ng/mL (3.3 pM) capsid proteins was achieved with conveni

98 The primary end point was a PSA level of 0.2 ng/mL or lower within 12 months of starting abiraterone

99 s prescribed level of 6 PSA responses of 0.2 ng/mL or lower, although 5 responses were observed.

100 1.2 ng/mL, with a limit of detection of 0.2 ng/mL, comparable to GC/MS.

101 state-specific antigen rises of at least 0.2 ng/mL.

102 The assay shows an IC50 of 4.5 +/- 1.2 ng/mL, with a limit of detection of 0.2 ng/mL, comparabl

103 2-158.4 ng/mL; interquartile range, 4.2-10.2 ng/mL) were finally eligible for this retrospective anal

104 typical bacteria (2.5 ng/mL; IQR, 0.29-12.2 ng/mL; P < .01).

105 o 1062.0 ng/mL (mean +/- SD: 191.7 +/- 354.2 ng/mL).

106 lomer-based PFASs was in the range < LOD-6.2 ng g(-1) dw.

107 oncentrations of 17beta-estradiol (E2beta; 2 ng/L and 50 ng/L) during four distinct stages of develop

108 on to rats of a single small dose of Hi1a (2 ng/kg) up to 8 h after stroke induction by occlusion of

109 lgorithm (hs-cTnI<5 ng/L and 1-hour change<2 ng/L), and the 0/1-hour algorithm recommended in the Eur

110 rategies: limit of detection (LOD, hs-cTnI<2 ng/L), single cutoff (hs-cTnI<5 ng/L), 1-hour algorithm

111 ccharide (LPS) administration at a dose of 2 ng/kg of body weight on motivation in 21 healthy human s

112 re in the 50-60% range and sensitivity was 2 ng/mL for CBDV, 4 ng/mL for CBG and THCV, and 7 ng/mL fo

113 tion were determined as 0.1-1ng/ml and 10(-2)ng/ml, respectively.

114 .05-0.54 ng/mL) than atypical bacteria (0.20 ng/mL; IQR, <0.05-0.87 ng/mL; P = .05), and typical bact

115 1-T2 with Gleason score, 7 and/or PSA, 10-20 ng/mL).

116 pain was evident in the insufficient (13-20 ng/l) and deficient (<13 ng/l) 25(OH)D status groups (OR

117 Lower limits of detection (2-20 ng/mL) were obtained using the CIL method.

118 , limits of quantification in the range 3-20 ng mL(-1), with reproducibility (%RSD < 10%; n = 6) and

119 ticipants at 80 ng, while AE incidence at 20 ng was similar to placebo.

120 parent in those with 25(OH)D status below 20 ng/l.

121 Weekly i.n. GSK2245035 20 ng was well tolerated and reduced allergic reactivity to

122 spectively) but not in those with status >20 ng/l (OR = 0.8,95% CI 0.5-1.4) (p = 0.003 for interactio

123 /mL; or T1 to 2, Gleason = 7, and PSA </= 20 ng/mL).

124 mL; T2b to 2c, Gleason </= 6, and PSA </= 20 ng/mL; or T1 to 2, Gleason = 7, and PSA </= 20 ng/mL).

125 e in the odds of vitamin D deficiency (</=20 ng/mL) [odds ratio (95% CI): 1.19 (1.06, 1.35) for molar

126 n lesions, and baseline serum tryptase </=20 ng/mL.

127 zed 25-hydroxyvitamin D [25(OH)D] levels <20 ng/mL).

128 hydroxyvitamin D [25(OH)D] concentration <20 ng/mL, is correlated with a more atherogenic lipid profi

129 occurred at a threshold concentration of 20 ng/ml and D2/3 occupancies of 43% (caudate), 25% (putame

130 lanted s.c. with slow-release E2 pellets (20 ng/day for 90 days).

131 1.1, alpha-fetoprotein level greater than 20 ng/mL, multiple tumors, and ALBI grade 2 or 3 were assoc

132 to 199 ng/m(3) for chlorpyrifos, 0.03 to 20 ng/m(3) for chlorpyrifos-oxon, < LOD (limit of detection

133 d prostate-specific antigen [PSA] 10.1 to 20 ng/mL; T2b to 2c, Gleason </= 6, and PSA </= 20 ng/mL; o

134 (80-120%) over the evaluated range (0.5-200 ng mL(-1)).

135 =10% improvement), and urinary cotinine (200 ng/ml detection limit) without deterioration in the othe

136 (at systemic plasma concentrations of >/=200 ng/mL) resulted in an increased brain concentration of e

137 erum alpha-fetoprotein level higher than 200 ng/mL (hazard ratio: 9.94 [95% CI: 2.82, 35.06], P = .00

138 rom 0 to 24 hours increased from 628 to 2054 ng h/ml (P<0.001).

139 showed concentrations up to 6.9, 23, and 21 ng g(-1) ww, respectively.

140 (P=0.03), and trough levels increased to 218 ng/ml (P=0.03), above the 90th percentile for the 5-mg d

141 perfluorooctanoic acid (PFOA) as high as 220 ng L(-1), 160 ng L(-1), and 120 ng L(-1), respectively.

142 dose (trough concentration = 0.822 and 1.23 ng/mL for weeks 1 and 2, respectively, with 24 mg; troug

143 s [SD, 5.8]; mean baseline testosterone, 234 ng/dL [SD, 65.1]), 247 were assigned to receive testoste

144 feed contained summation operatorPOPs of 24 ng/g ww.

145 high sensitivity of 194nA/(ng/ml) and 240nA/(ng/ml), respectively for single and double membrane base

146 s and 10005 peptides were identified from 25 ng of a HeLa digest using single-shot analysis with a SC

147 al cTnI concentrations ranging from 0 to 250 ng/mL were detected.

148 entile of a healthy reference population (26 ng/L), whereas 56% of patients had levels above the 99th

149 f 2 serum testosterone levels lower than 275 ng/dL (82 men assigned to placebo, 88 to testosterone) a

150 idual fish levels ranged from 0.16 to 138.29 ng/g wet weight and lipid-normalized concentrations from

151 ific antigen level, 5 ng/mL; range, 0.25-294 ng/mL), 362 (68)Ga-PSMA PET-positive lymph nodes (LNs) w

152 were stimulated with low-dose TNFalpha (0.3 ng/ml) in a microfluidic channel that produced a linear

153 average, serum PFOS concentrations were 2.3 ng/mL (95%CI: 0.40, 4.3) higher in participants with air

154 (range, 0.3-119.0 ng/mL; mean, 10.1 +/- 21.3 ng/mL) and negative findings on conventional imaging (CT

155 l samples at lower concentrations (16.9-49.3 ng g(-1) dw).

156 ifos-oxon, < LOD (limit of detection) to 7.3 ng/m(3) for azinphos-methyl, and < LOD to 0.8 ng/m(3) fo

157 of water daily that contains between 2 and 3 ng iAs/mL is exposed to approximately the same amount of

158 lation (<5 ng/L at presentation or change <3 ng/L and <99th centile at 3 hours).

159 (>/=7.42 ng/L versus <limit of detection [<3 ng/L]; adjusted odds ratio, 2.87; 95% confidence interva

160 ata, men with PSA greater than or equal to 3 ng/mL after negative transrectal US-guided biopsy findin

161 sis factor alpha (TNFalpha) detection with 3 ng/mL of LOD.

162 Here, we report that IL-33 (30 ng/mL), a member of the IL-1 family of cytokines, admini

163 Less than 30 ng minimum detectable quantity (MDQ) is demonstrated.

164 th initial 25(OH)D levels of greater than 30 ng/mL, reduced asthma/recurrent wheeze in the offspring

165 abundant PFAS (geometric mean: 5.80 and 2.32 ng/mL, respectively).

166 ared to MS and AIF-MS with LOQs of 1.24-4.32 ng muL(-1) and relative process standard deviations of 9

167 (limits of quantification between 0.5 and 32 ng L(-1)).

168 ian baseline circulating PCSK9 level was 323 ng/mL (interquartile range, 258-406 ng/mL).

169 edema (4.96 +/- 1.13 ng/mL vs 2.10 +/- 0.34 ng/mL; p = 0.023).

170 Acute consumption (1.34 ng/bee) impaired locomotion, caused hyperactivity (veloc

171 h of consuming a single sublethal dose (1.34 ng/bee), foragers showed excitation and significantly in

172 calibration curves were 1.42, 1.00, and 1.34 ng/mL, respectively, which coincides with expected IFX c

173 FABP1 > 350 ng/mL was associated with significantly higher risk of d

174 s significantly higher D-dimer levels (>3500 ng/mL) were in found in livers with poor graft function.

175 levels of ALT and D-dimers were low (</=3500 ng/mL), whereas significantly higher D-dimer levels (>35

176 with concentrations ranging from 542 to 3645 ng/g dry weight (dw).

177 ebo (decrease of 2.02+/-2.32 vs. 0.56+/-1.39 ng per milliliter, P=0.02).

178 brain injury patients (mean = 3.54 +/- 3.39 ng/mL, peak = 7.13 +/- 6.09 ng/mL) but undetectable in a

179 ensitivity (limits of detection of 7 and 0.4 ng/mL for OTA and FB1, respectively), and high selectivi

180 antigen (PSA) of 6.4 ng/mL (range, 2.2-158.4 ng/mL; interquartile range, 4.2-10.2 ng/mL) were finally

181 e array showed an IC50 value of 37.1 +/- 2.4 ng mL(-1) (n = 9), a detection limit of 11.1 ng mL(-1),

182 er (26-121 ng/mL; mean +/- SD: 60.7 +/- 52.4 ng/mL).Despite the selection of healthy volunteers with

183 edian prostate-specific antigen (PSA) of 6.4 ng/mL (range, 2.2-158.4 ng/mL; interquartile range, 4.2-

184 ange and sensitivity was 2 ng/mL for CBDV, 4 ng/mL for CBG and THCV, and 7 ng/mL for CBD.

185 up 9346) of PSA </= 0.2, > 0.2 to 4, and > 4 ng/mL.

186 with plasma concentrations of NDI-010976 >4 ng/mL.

187 n, achieving a limit of detection (LOD) of 4 ng of (99)Tc (2.5 Bq), a reproducibility of 6%, and a re

188 Results Elevated baseline troponin I (> 40 ng/L) and T (> 14 ng/L), occurring in 56 of 412 (13.6%)

189 EBC showed increased values (100-400 ng m(-3)) in the Kara Strait, Kara Sea, and Kola Peninsu

190 the effect of 4-week infusion of AngII (400 ng/kg per minute) in APA-KO and wild-type mice.

191 Having AFP below 400 ng/ml was associated with longer survival (16 vs. 7 mont

192 protein concentration (<400 ng/mL and >/=400 ng/mL).

193 serum alpha-fetoprotein concentration (<400 ng/mL and >/=400 ng/mL).

194 iagnosing nvHCC, Having a AFP value over 400 ng/ml was associated with aggressive tumour behaviour an

195 e stage tumours (P < 0.001) had AFP over 400 ng/ml.

196 was 323 ng/mL (interquartile range, 258-406 ng/mL).

197 ies and late gadolinium enhancement (>/=7.42 ng/L versus <limit of detection [<3 ng/L]; adjusted odds

198 y were between 2.17 ng/g dw for TMPP and 427 ng/g dw for triphenyl phosphate (TPhP).

199 was detected in 9/35 samples (range, 6.0-43 ng DexEq L(-1)); however, none of the recognized GR-acti

200 artile range (IQR) increase in PBB-153 (0.43 ng/mL), the OR (any thyroid disease)=1.12; (95% CI: 0.83

201 SigmaPFASs ranged between 0.66-45 ng per g of wet weight of the whole body.

202 e threshold level for homes with cats was 46 ng/m(2) Fel d 1 (92% sensitivity, 94.9% specificity).

203 24 mg; trough concentration = 0.993 and 1.47 ng/mL for weeks 1 and 2, respectively, with 32 mg).

204 In vitro IC50 values were 11-48 ng/mL in HER2 3+ SK-BR-3 and KPL-4 (7 inactive) for the

205 e (field-relevant daily intakes of 1.42-3.48 ng/bee/day) impaired bee ability to ascend.

206 6v2.0 chip in control and AngII infused (490 ng/kg/min) hypertensive mice.

207 rations ( summation operatorPFAAs = 0.06-0.5 ng g(-1) dw) while the sum of fluorotelomer-based PFASs

208 mum 20(th) century GEM levels of 3.9 +/- 0.5 ng m(-3) were 15 +/- 4 times the natural Holocene backgr

209 s of quantitation (median, approximately 0.5 ng mL(-1)), linearity (>/=0.99), and accuracy (80-120%)

210 A PSA nadir value of greater than 0.5 ng/mL following radiation and androgen deprivation thera

211 ecific antigen [PSA] failure, PSA nadir >0.5 ng/mL, PSA doubling time <9 months, and interval to PSA

212 detected with very high sensitivity were 2.5 ng on the Ion Torrent platform and 10 ng on Illumina.

213 t clinically relevant concentrations (</=2.5 ng/mL), causes substantial membrane depolarization conco

214 7 ng/mL; P = .05), and typical bacteria (2.5 ng/mL; IQR, 0.29-12.2 ng/mL; P < .01).

215 6 ng/mL at first measurement and 38.6+/-36.5 ng/mL at second measurement) than in controls (4.1+/-7.6

216 a concentration ranging between 0.3 and 6.5 ng/m(3) in the PM2.5 fraction.

217 pse (mean prostate-specific antigen level, 5 ng/mL; range, 0.25-294 ng/mL), 362 (68)Ga-PSMA PET-posit

218 ng required <1 h to complete and consumed <5 ng of each HMO and <0.5 mug of protein.

219 hs-cTnI<5 ng/L), 1-hour algorithm (hs-cTnI<5 ng/L and 1-hour change<2 ng/L), and the 0/1-hour algorit

220 Troponin concentrations <5 ng/L at presentation identified 17% of patients with ren

221 With Acute Coronary Syndrome) population (<5 ng/L at presentation or change <3 ng/L and <99th centile

222 D, hs-cTnI<2 ng/L), single cutoff (hs-cTnI<5 ng/L), 1-hour algorithm (hs-cTnI<5 ng/L and 1-hour chang

223 er proportion of tacrolimus trough levels <5 ng/ml, which continued to be significant after adjustmen

224 mance of a cardiac troponin I threshold of 5 ng/L at presentation as a risk stratification tool in pa

225 py; prostate-specific antigen greater than 5 ng/mL; and a Karnofsky performance score of 70% or highe

226 s below the risk stratification threshold (5 ng/L) at presentation were reported for a primary outcom

227 keletal myotubes were treated with IGF-1 (50 ng/ml) with or without 0.5 microM CX-5461 (CX), an inhib

228 s of 17beta-estradiol (E2beta; 2 ng/L and 50 ng/L) during four distinct stages of development: gonad

229 5605 unique peptides were identified from 50 ng of an E. coli digest, and 2158 protein groups and 100

230 mography, and serum testosterone levels > 50 ng/mL.

231 between raw beef and horsemeat using just 50 ng of total extracted mitochondrial DNA ( approximately

232 factory with a mean limit of detection of 50 ng/L, relative standard deviation lower than 20% and ove

233 Fetal fibronectin levels of 50 ng/mL or greater at 16 to 22 weeks identified 30 of 410

234 rostate-specific antigen levels less than 50 ng/mL, and enrolled within 6 months of diagnosis.

235 in 2 or 3 dimensions with or without TNF (50 ng/mL for 6-24 hours).

236 ured enteroids, incubated these with TNF (50 ng/mL, 24 hours), and quantified messenger RNAs.

237 In contrast, exposure to 50 ng/L E2beta during SSC development altered phenotypic ra

238 Larval injections of 125-500 ng of Diap1 dsRNA resulted in dose-dependent mortality w

239 ensitive to PQS concentrations as low as 500 ng/ml.

240 In-vivo MPI mouse images of a 512 ng bolus and a 21.5 ms acquisition time allow for captur

241 as 67 years, and the median PSA level was 53 ng per milliliter.

242 ng/mL; interquartile range [IQR], <0.05-0.54 ng/mL) than atypical bacteria (0.20 ng/mL; IQR, <0.05-0.

243 hest in the high-elevation barren site ( 560 ng NO-N m(-2) s(-1) ).

244 giving limits of detection in the range 1-6 ng mL(-1), limits of quantification in the range 3-20 ng

245 L in the vitamin D3 + calcium group and 31.6 ng/mL in the placebo group.

246 of surfactant protein D (46.6 ng/mL vs 34.6 ng/mL, p=0.0018) and CA19-9 (53.7 U/mL vs 22.2 U/mL; p<0

247 PBB levels were higher in cases (46.3+/-38.6 ng/mL at first measurement and 38.6+/-36.5 ng/mL at seco

248 terone was blunted with older age (beta=-4.6 ng/dL per 10 years, P<0.0001).

249 aseline values of surfactant protein D (46.6 ng/mL vs 34.6 ng/mL, p=0.0018) and CA19-9 (53.7 U/mL vs

250 ond measurement) than in controls (4.1+/-7.6 ng/mL, p<0.01 for both).

251 L(-1), and a dynamic range from 17.3 to 79.6 ng mL(-1).

252 in a range of expected concentrations from 6 ng/L to 540 mug/L.

253 ean males: A) 10-h overnight GCG infusion (6 ng/[kg x min]) followed by 3-h infusion of GCG, octreoti

254 rough levels below a series of thresholds <6 ng/ml and the mean tacrolimus levels before dnDSA develo

255 ) emerged at a threshold concentration of 60 ng/ml, and D2/3 occupancies of 61% (caudate), 49% (putam

256 ay demonstrated a wide linear range 0.03-600 ng/mL) with a good linear correlation coefficient (0.999

257 ensitive estimation of empagliflozin (25-600 ng mL(-1)) in human plasma using dapagliflozin as an int

258 tration-time curve further increased to 6045 ng h/ml (P=0.03), and trough levels increased to 218 ng/

259 , with concentrations ranging from 77 to 636 ng per milliliter.

260 on molecule-1 (VCAM-1) (Group I: 0.34 (0.67) ng/mL, Group II: 0.11 (0.11) ng/mL, P = .01); vascular e

261 ceptive use, women with low AMH values (<0.7 ng/mL [n = 84]) did not have a significantly different p

262 1.0 ng/L) compared with controls (mean, 34.7 ng/L) (P < .001) and had high diagnostic accuracy for pa

263 mL for CBDV, 4 ng/mL for CBG and THCV, and 7 ng/mL for CBD.

264 ntradermal allergen injections (containing 7 ng of Phl p 5 major allergen) or a histamine control.

265 men, aged 64.8 years +/- 8.2 (median PSA, 7 ng/mL), were included.

266 er than the 2016 U.S. EPA advisory level (70 ng L(-1)), and was regenerated and reused multiple times

267 owest in the acidic and SOM-rich soils (4-72 ng NO-N m(-2) s(-1) ), but were highest in the high-elev

268 /g dw for tripropyl phosphate (TPP) and 7290 ng/g dw for TBOEP; for ash, they were between 2.17 ng/g

269 n in dust (1200 ng/g), followed by EFRs (730 ng/g) and HBCDDs (190 ng/g).

270 5% CI: 0.33); 1.44 for an IQR increase (0.75 ng/mL) in serum PBB-153].

271 (100 pg/mL higher adrenaline predicted 2.75 ng/mL higher syndecan-1, P < 0.001).

272 e threshold level for homes with dogs was 75 ng/m(2) Can f 1 (96.8% sensitivity, 96% specificity), an

273 ivity towards cardiac troponin I [1.7microA/(ng/mL) in phosphate buffer], but suffered from surface f

274 g/m(3) for azinphos-methyl, and < LOD to 0.8 ng/m(3) for azinphos-methyl-oxon.

275 line serum 25-hydroxyvitamin D level of 32.8 ng/mL, supplementation with vitamin D3 and calcium compa

276 s increased in patients with MCI (mean, 42.8 ng/L) and patients with AD dementia (mean, 51.0 ng/L) co

277 s were lower (2.2 [0.9-6.2] vs 6.9 [4.8-9.8] ng/mL; p < 0.05) at the end of the experiment.

278 uration <1 day) in 93% of participants at 80 ng, while AE incidence at 20 ng was similar to placebo.

279 (Cmax) ranged between 1310 ng/mL and 34 800 ng/mL and was reached in a median time (tmax) between 1.

280 summation operatorPOPs concentration of 802 ng/g ww, whereas the pig-based feed contained summation

281 ng sites with the highest concentration (812 ng/L) at the first sampling location downstream from the

282 lood plasma samples, achieving a LOD of 0.86 ng/mL.

283 ypical bacteria (0.20 ng/mL; IQR, <0.05-0.87 ng/mL; P = .05), and typical bacteria (2.5 ng/mL; IQR, 0

284 quantify anti-HPV16 E7 antibody down to 2.87 ng/mL.

285 a continuous ghrelin/placebo infusion (16.9 ng/kg/min) was administered.

286 , serum 25-hydroxyvitamin D levels were 43.9 ng/mL in the vitamin D3 + calcium group and 31.6 ng/mL i

287 ong those with high-normal aldosterone (>/=9 ng/dL, n = 202), we found no significant association bet

288 models, in those with normal aldosterone (<9 ng/dL, n = 1163), participants in the highest 2 potassiu

289 eld-relevant thiamethoxam doses of 1.96-2.90 ng/bee/day.

290 cretes extremely high amounts of PGE2 (45-90 ng/mg protein) within their excretory/secretory products

291 of MTD and endoxifen concentrations > 1,900 ng/mL.

292 elopment were differentially expressed at 91 ng/L and higher.

293 edian fasting C-peptide was 0.43 (0.19-0.93) ng/mL; median insulin requirement was 0.38 (0.04-0.5) U/

294 ith up to 97 ng g(-1) wet weight (ww) and 94 ng g(-1) ww in birch leaves and spruce needles, respecti

295 lowest limits of quantification (LOQ) (0.96 ng muL(-1)) and featured the lowest relative process sta

296 rable with the LCCPs concentrations (116-960 ng/g dw).

297 ons in vegetative compartments with up to 97 ng g(-1) wet weight (ww) and 94 ng g(-1) ww in birch lea

298 Each additional ng/mL/year decrease of logAMH was associated with a sign

299 fluorescence sensor can detect as low as sub-ng/muL standard DNA and 10(1) copies of Salmonella typhi

300 ) for 21 targets (mainly pyrethroids) at sub-ng/L levels.

301 llowed quantification of a model drug in the ng/mL range with single-stage MS, after correction for s

302 rochemically sense biomarkers sensitively to ng/ml range with negligible nonspecific binding and fals

303 ), 41 +/- 38 (char), and 9.9 +/- 5.9 (trout) ng g(-1) wet weight.